KCTD7-related progressive myoclonus epilepsy

Epileptic Disord. 2016 Sep 1;18(S2):115-119. doi: 10.1684/epd.2016.0856.


Progressive myoclonic epilepsy associated with KCTD7 mutations has been reported in 19 patients from 12 families. Patients show homozygous mutations in the coding regions of the KCTD7 gene. The disease starts in infancy. Patients typically show an initial severe epileptic disorder, with abundant epileptiform discharges on EEG and myoclonic seizures in the foreground, associated with cognitive regression and ataxia. Continuous multifocal myoclonus aggravated by action is observed in more than half of the cases. After a few years, the disease tends to stabilize and long survival can be expected. Some patients remain able to walk independently. The severity of the disease is variable from one patient to another, even within the same family. It is hypothesized that the epileptic disorder may influence the neurological regression observed in patients.

Keywords: KCTD7; encephalopathy; infancy; progressive myoclonus epilepsies.

Publication types

  • Review

MeSH terms

  • Humans
  • Myoclonic Epilepsies, Progressive / genetics*
  • Myoclonic Epilepsies, Progressive / physiopathology*
  • Potassium Channels / genetics*


  • KCTD7 protein, human
  • Potassium Channels